Apellis Pharmaceuticals Inc (APLS)
29.47
-0.38
(-1.27%)
USD |
NASDAQ |
Sep 27, 16:00
29.47
0.00 (0.00%)
After-Hours: 20:00
Apellis Pharmaceuticals 30-Day Average Daily Volume: 1.511M for Sept. 27, 2024
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
Date | Value |
---|---|
September 27, 2024 | 1.511M |
September 26, 2024 | 1.500M |
September 25, 2024 | 1.454M |
September 24, 2024 | 1.436M |
September 23, 2024 | 1.398M |
September 20, 2024 | 1.384M |
September 19, 2024 | 1.288M |
September 18, 2024 | 1.279M |
September 17, 2024 | 1.309M |
September 16, 2024 | 1.329M |
September 13, 2024 | 1.350M |
September 12, 2024 | 1.481M |
September 11, 2024 | 1.487M |
September 10, 2024 | 1.479M |
September 09, 2024 | 1.485M |
September 06, 2024 | 1.477M |
September 05, 2024 | 1.474M |
September 04, 2024 | 1.475M |
September 03, 2024 | 1.504M |
August 30, 2024 | 1.506M |
August 29, 2024 | 1.518M |
August 28, 2024 | 1.540M |
August 27, 2024 | 1.533M |
August 26, 2024 | 1.557M |
August 23, 2024 | 1.578M |
Date | Value |
---|---|
August 22, 2024 | 1.616M |
August 21, 2024 | 1.635M |
August 20, 2024 | 1.622M |
August 19, 2024 | 1.620M |
August 16, 2024 | 1.648M |
August 15, 2024 | 1.658M |
August 14, 2024 | 1.644M |
August 13, 2024 | 1.668M |
August 12, 2024 | 1.698M |
August 09, 2024 | 1.792M |
August 08, 2024 | 1.768M |
August 07, 2024 | 1.664M |
August 06, 2024 | 1.666M |
August 05, 2024 | 1.654M |
August 02, 2024 | 1.725M |
August 01, 2024 | 1.678M |
July 31, 2024 | 1.524M |
July 30, 2024 | 1.493M |
July 29, 2024 | 1.485M |
July 26, 2024 | 1.479M |
July 25, 2024 | 1.473M |
July 24, 2024 | 1.434M |
July 23, 2024 | 1.413M |
July 22, 2024 | 1.361M |
July 19, 2024 | 1.340M |
30-Day Average Daily Volume Range, Past 5 Years
532852.2
Minimum
Mar 17 2021
8.038M
Maximum
Aug 25 2023
1.434M
Average
1.186M
Median
30-Day Average Daily Volume Benchmarks
EyePoint Pharmaceuticals Inc | 569702.5 |
Cassava Sciences Inc | 1.737M |
Adverum Biotechnologies Inc | 172803.6 |
Rocket Pharmaceuticals Inc | 883167.1 |
Regenxbio Inc | 472742.8 |